Australia’s investment market has a track record of supporting the commercialisation of some of the most successful MedTech companies in the world and that appetite remains strong says Kyahn Williamson, Head of Investor Communication.
The biotechnology sector is a significant contributor to both the health of our world today but, with so many companies vying for investor attention and dollars, how do you cut through the noise and keep investors with you for the whole journey?
I felt a lot like a proud Mum last Friday morning watching two of my “children” come of age.
Nothing quite prepares your for the frenzy of tens of thousands of people who descend on San Francisco for the biggest investment event on the healthcare and biotech calendar.
Investment in the biotech sector can be highly lucrative for the educated, patient investor. For the uninformed and inexperienced, biotechnology can be a potholed road.
This week we’re taking a moment to reflect on the work of our iComm team and how it is evolving to keep pace with a rapidly developing industry. The Buchan iComm team has extensive expertise in the area of healthcare …